DK0060257814
DK0060257814
Zealand Pharma A/S
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 15.79B EUR | 20.1B EUR | 20.84B EUR | 32.93B EUR |
Enterprise Value | 2.47B EUR | 16.47B EUR | 17.41B EUR | 28.76B EUR |
Valuation Multiples | ||||
Trailing P/E | 6.16x | 7.34x | 3.26x | 4.85x |
Forward P/E | 31.93x | -- | -- | -- |
Price to Sales | 3.4x | 4.33x | 2.26x | 3.58x |
Price to Book | 0.92x | 1.12x | 1.44x | 2.22x |
EV/Revenue | 0.53x | 3.55x | 1.88x | 3.12x |
EV/EBITDA | 1.06x | 5.33x | 2.38x | 3.74x |
Price to FCF (P/FCF) | -- | -- | 3.31x | 4.72x |
EV/FCF | -- | -- | 2.77x | 4.13x |
FCF Yield | -13.07% | -9.11% | 30.17% | 21.17% |